Press Contact
Ellen Mullally
Phone: 410-992-3124
Email: emullally@paltmed.org
JAMDA
October 10, 2019
Showing 4641 - 4650 of 8235 results
JAMDA
October 10, 2019
Lessons Learned From Implementation of the Indiana SMART Campaign to Reduce Nursing Home Polypharmacy
JAMDA
October 8, 2019
Sleep Duration and the Risk of Dementia: A Systematic Review and Meta-analysis of Prospective Cohort Studies
Epidemiologic studies have reported inconsistent findings about the association between sleep duration and the risk of dementia. We aimed to clarify this association by method of meta-analysis.
JAMDA
October 8, 2019
Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD
Benzodiazepines and related drugs (BDZRs) have been associated with an increased risk of Alzheimer's disease (AD) in later life. Despite this, it remains unclear whether ongoing BDZR use may further accelerate cognitive decline in those diagnosed with mild to moderate AD.
Podcast
October 7, 2019
CMDA Journal Club | October 3rd Meeting
JAMDA
October 4, 2019
The Presence of a Geriatrician in a Nursing Home Could Prevent Hospitalization
JAMDA
October 3, 2019
Leisure Activities and All-Cause Mortality Among the Chinese Oldest-Old Population: A Prospective Community-Based Cohort Study
To investigate associations between leisure activities, examining each activity separately and in combination, and all-cause mortality among the Chinese oldest-old (≥80 years) population.
JAMDA
October 3, 2019
Stopping Eating and Drinking by Advance Directives (SED by AD) in Assisted Living and Nursing Homes
The Ethics Subcommittee of AMDA–The Society for Post-Acute and Long-Term Care Medicine (“The Society”) presents arguments for and against Stopping Eating and Drinking by Advance Directives (SED by AD). SED by AD is a type of advance directive in which a proxy is instructed to stop offering food and fluids ...
JAMDA
October 3, 2019
A Randomized Trial of Alerting to Low Glycated Hemoglobin Level in Older Adults: Results of the Low Indexes of Metabolism Intervention Trial B (LIMIT-B)
The benefit of alerting clinical staff to low plasma glycated hemoglobin (HbA1c) in patients aged 75 years and older who receive antidiabetic drugs remains uncertain.
JAMDA
October 3, 2019